Tracy Ann Perry

492 total citations
6 papers, 182 citations indexed

About

Tracy Ann Perry is a scholar working on Pharmacology, Genetics and Computational Theory and Mathematics. According to data from OpenAlex, Tracy Ann Perry has authored 6 papers receiving a total of 182 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 2 papers in Genetics and 2 papers in Computational Theory and Mathematics. Recurrent topics in Tracy Ann Perry's work include Cholinesterase and Neurodegenerative Diseases (2 papers), Computational Drug Discovery Methods (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Tracy Ann Perry is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (2 papers), Computational Drug Discovery Methods (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Tracy Ann Perry collaborates with scholars based in United States. Tracy Ann Perry's co-authors include Harold W. Holloway, Nigel H. Greig, Debomoy K. Lahiri, Arnold Brossi, Tony Giordano, Xiaoxiang Zhu, Peter R. Mouton, Ananda Weerasuriya, Qian-sheng Yu and Jack T. Rogers and has published in prestigious journals such as Journal of Medicinal Chemistry, Experimental Neurology and Neurobiology of Aging.

In The Last Decade

Tracy Ann Perry

6 papers receiving 177 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tracy Ann Perry United States	5	62	41	37	33	27	6	182
Fengju Jia China	10	100 1.6×	71 1.7×	33 0.9×	13 0.4×	48 1.8×	17	297
Na-Young Choi South Korea	7	87 1.4×	72 1.8×	19 0.5×	9 0.3×	11 0.4×	13	206
Inge Snoeren Germany	5	110 1.8×	59 1.4×	21 0.6×	10 0.3×	7 0.3×	9	209
Masaaki Funata Japan	9	153 2.5×	57 1.4×	16 0.4×	35 1.1×	23 0.9×	11	363
Edward Yang United States	6	175 2.8×	103 2.5×	19 0.5×	8 0.2×	12 0.4×	16	348
Hilda Solanoy United States	4	67 1.1×	30 0.7×	19 0.5×	21 0.6×	36 1.3×	4	158
Hongmei Cao United States	6	163 2.6×	211 5.1×	38 1.0×	12 0.4×	20 0.7×	8	343
David Harrison United States	9	140 2.3×	36 0.9×	13 0.4×	25 0.8×	6 0.2×	18	269
Mahua Maulik Canada	10	140 2.3×	185 4.5×	35 0.9×	13 0.4×	19 0.7×	18	352
Raquel Pascua‐Maestro Spain	7	195 3.1×	76 1.9×	101 2.7×	9 0.3×	23 0.9×	7	337

Countries citing papers authored by Tracy Ann Perry

Since Specialization

Citations

This map shows the geographic impact of Tracy Ann Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tracy Ann Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tracy Ann Perry more than expected).

Fields of papers citing papers by Tracy Ann Perry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tracy Ann Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tracy Ann Perry. The network helps show where Tracy Ann Perry may publish in the future.

Co-authorship network of co-authors of Tracy Ann Perry

This figure shows the co-authorship network connecting the top 25 collaborators of Tracy Ann Perry. A scholar is included among the top collaborators of Tracy Ann Perry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tracy Ann Perry. Tracy Ann Perry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Perry, Tracy Ann, Ananda Weerasuriya, Peter R. Mouton, Harold W. Holloway, & Nigel H. Greig. (2004). Pyridoxine-induced toxicity in rats: a stereological quantification of the sensory neuropathy. Experimental Neurology. 190(1). 133–144. 44 indexed citations

2.

Greig, Nigel H., Tony Giordano, Xiaoxiang Zhu, et al.. (2004). Thalidomide-based TNF-α inhibitors for neurodegenerative diseases. Acta Neurobiologiae Experimentalis. 64(1). 1–9. 42 indexed citations

3.

Greig, Nigel H., Tadanobu Utsuki, Yue Wang, et al.. (2004). P1-414 Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers amyloid-beta peptide in rodents: a new treatment strategy for Alzheimer's disease. Neurobiology of Aging. 25. S216–S216. 4 indexed citations

4.

Greig, Nigel H., Qian‐sheng Yu, Weiming Luo, et al.. (2003). Racemic N1-Norphenserine and Its Enantiomers: Unpredicted Inhibition of Human Acetyl- and Butyrylcholinesterase and β-Amyloid Precursor Protein in vitro. Heterocycles. 61(1). 529–529. 13 indexed citations

5.

Zhu, Xiaoxiang, Tony Giordano, Qian-sheng Yu, et al.. (2003). Thiothalidomides: Novel Isosteric Analogues of Thalidomide with Enhanced TNF-α Inhibitory Activity. Journal of Medicinal Chemistry. 46(24). 5222–5229. 75 indexed citations

6.

Quinones, Ralph, L. Álvarez, Cristina Suárez, et al.. (1992). Transplantation of Human Fetal Mesencephalic Tissue in Caudate Nucleus as a Treatment for Parkinson′s Disease. Long‐Term Follow‐Up. Neural Plasticity. 3(4). 323–324. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact